These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 16487439)

  • 1. Levels of dyslipidaemia and improvement in its management in England: results from the Health Survey for England 2003.
    Primatesta P; Poulter NR
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):292-8. PubMed ID: 16487439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving lipid profiles and increasing use of lipid-lowering therapy in England: results from a national cross-sectional survey - 2006.
    Mindell J; Aresu M; Zaninotto P; Falaschetti E; Poulter N
    Clin Endocrinol (Oxf); 2011 Nov; 75(5):621-7. PubMed ID: 21575024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low HDL-cholesterol is common in European Type 2 diabetic patients receiving treatment for dyslipidaemia: data from a pan-European survey.
    Bruckert E; Baccara-Dinet M; Eschwege E
    Diabet Med; 2007 Apr; 24(4):388-91. PubMed ID: 17335463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement in hypertension management in England: results from the Health Survey for England 2003.
    Primatesta P; Poulter NR
    J Hypertens; 2006 Jun; 24(6):1187-92. PubMed ID: 16685220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of dyslipidaemia in apparently healthy professionals in Asaba, South South Nigeria.
    Odenigbo CU; Oguejiofor OC; Odenigbo UM; Ibeh CC; Ajaero CN; Odike MA
    Niger J Clin Pract; 2008 Dec; 11(4):330-5. PubMed ID: 19320405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of low HDL-cholesterol in a pan-European survey of 8545 dyslipidaemic patients.
    Bruckert E; Baccara-Dinet M; McCoy F; Chapman J
    Curr Med Res Opin; 2005 Dec; 21(12):1927-34. PubMed ID: 16368042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: the National Health and Nutrition Examination Survey 2003-2004.
    Ghandehari H; Kamal-Bahl S; Wong ND
    Am Heart J; 2008 Jul; 156(1):112-9. PubMed ID: 18585505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current cardiovascular risk management patterns with special focus on lipid lowering in daily practice in Switzerland.
    Jaussi A; Noll G; Meier B; Darioli R
    Eur J Cardiovasc Prev Rehabil; 2010 Jun; 17(3):363-72. PubMed ID: 20168234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma lipids and lipoprotein reference values, and the prevalence of dyslipoproteinemia in Canadian adults. Canadian Heart Health Surveys Research Group.
    MacLean DR; Petrasovits A; Connelly PW; Joffres M; O'Connor B; Little JA
    Can J Cardiol; 1999 Apr; 15(4):434-44. PubMed ID: 10322253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of lipid-lowering treatment according to lipid level.
    Pilote L; Ho V; Lavoie F; Coupal L; Zowall H; Grover SA
    Can J Cardiol; 2005 Jun; 21(8):681-7. PubMed ID: 16003451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and control of dyslipidemia among persons with diabetes in the United States.
    Jacobs MJ; Kleisli T; Pio JR; Malik S; L'Italien GJ; Chen RS; Wong ND
    Diabetes Res Clin Pract; 2005 Dec; 70(3):263-9. PubMed ID: 15890427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum lipid levels and the prevalence of dyslipidaemia among rural and urban Thai adults--are the NCEP III guidelines appropriate?
    Patel A; Woodward M; Stolk R; Suriyawongpaisal P; Neal B
    J Med Assoc Thai; 2005 Sep; 88(9):1242-50. PubMed ID: 16536111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and treatment of dyslipidemia are neglected in patients with peripheral artery disease.
    Poussa H; Strandberg TE; Tikkanen I; Kauhanen P; Lepäntalo M
    Scand Cardiovasc J; 2007 Jun; 41(3):138-41. PubMed ID: 17487761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twenty-year trends in serum cholesterol, hypercholesterolemia, and cholesterol medication use: the Minnesota Heart Survey, 1980-1982 to 2000-2002.
    Arnett DK; Jacobs DR; Luepker RV; Blackburn H; Armstrong C; Claas SA
    Circulation; 2005 Dec; 112(25):3884-91. PubMed ID: 16344385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women: The Lipid Treatment Assessment Project (L-TAP) 2.
    Santos RD; Waters DD; Tarasenko L; Messig M; Jukema JW; Ferrières J; Verdejo J; Chiang CW;
    Am Heart J; 2009 Nov; 158(5):860-6. PubMed ID: 19853709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contemporary management of dyslipidemia in high-risk patients: targets still not met.
    Yan AT; Yan RT; Tan M; Hackam DG; Leblanc KL; Kertland H; Tsang JL; Jaffer S; Kates ML; Leiter LA; Fitchett DH; Langer A; Goodman SG;
    Am J Med; 2006 Aug; 119(8):676-83. PubMed ID: 16887414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Status and management of blood lipids in Greek adults and their relation to socio-demographic, lifestyle and dietary factors: the ATTICA Study. Blood lipids distribution in Greece.
    Panagiotakos DB; Pitsavos C; Chrysohoou C; Skoumas J; Stefanadis C
    Atherosclerosis; 2004 Apr; 173(2):353-61. PubMed ID: 15064113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study.
    Hadaegh F; Harati H; Ghanbarian A; Azizi F
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):571-7. PubMed ID: 16874147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid levels and the use of lipid-lowering agents in England and Scotland.
    Primatesta P; Poulter NR
    Eur J Cardiovasc Prev Rehabil; 2004 Dec; 11(6):484-8. PubMed ID: 15580059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.